Assessing the Elevation of Cardiac Biomarkers and the Severity of COVID-19 Infection: A Meta-analysis
ABSTRACT - Purpose: Since December 2019, coronavirus disease 2019 infection has become a global pandemic. The cases of Coronavirus Disease 2019 (COVID-19)-related acute cardiac injury with unknown pathophysiologic mechanism has become increasingly prevalent. However, it is not yet understood how th...
Main Authors: | Cucnhat Walker, Subrata Deb, Hua Ling, Zhe Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Canadian Society for Pharmaceutical Sciences
2020-10-01
|
Series: | Journal of Pharmacy & Pharmaceutical Sciences |
Online Access: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31501 |
Similar Items
-
Relation between Cardiac Injury and Elevated Levels of Inflammatory Biomarkers in Patients with Severe COVID-19
by: Jing Li, MD, PhD, et al.
Published: (2021-02-01) -
Prognostic value of cardiac biomarkers in COVID-19 infection
by: Aakash Sheth, et al.
Published: (2021-03-01) -
Cardiac biomarkers and COVID-19: A systematic review and meta-analysis
by: Wen An, et al.
Published: (2021-09-01) -
Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection
by: Akitaka Yamamoto, et al.
Published: (2021-08-01) -
Biomarkers for severe COVID-19
by: Xin Li, et al.
Published: (2021-06-01)